About Antibody Registry
Antibody Registry is a company based in San Diego (United States) founded in 2010. It operates as a B2B. Antibody Registry operates in a competitive market with competitors including Genomenon, RareCan, Yaorongyun Digital Technology, Partex and Wuxu Data, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Website antibodyregistry.org
- Social X
Competitors of Antibody Registry
Antibody Registry operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomenon, RareCan, Yaorongyun Digital Technology, Partex and Wuxu Data, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genomenon.com | 2014 | Ann Arbor, United States | $36.84M | – | AI-based bioinformatics tools and genomic variants meta-database are developed. | |
| rarecan.com | 2019 | Hexham, United Kingdom | $755,199 | 9 | Cancer patient data is collected online for clinical trial researchers. | |
| pharnexcloud.com | 2020 | Shanghai, China | $15.63M | – | Provider of an online healthcare database platform | |
| partex.io | 2021 | Eschborn, Germany | – | – | Partex is focused on revolutionizing drug development with technology. | |
| wuxuwang.com | 2019 | Lanzhou, China | – | – | Medical information is delivered online for pharmaceutical sectors. | |
| desci.com | 2021 | Wollerau, Switzerland | – | – | Platform for sharing research manuscripts, data, code, and AI insights. |
Detailed competitors of Antibody Registry
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Antibody Registry
Websites that share an audience with Antibody Registry (antibodyregistry.org).
Websites whose visitors overlap most with Antibody Registry. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| antibodies.com | 98% | 90K | #447,792 | View details | |
| citeab.com | 96% | 601.8K | #63,627 | View details | |
| cytivalifesciences.com | 89% | 312.5K | #148,975 | View details | |
| corning.com | 84% | 606.5K | #95,499 | View details | |
| bioz.com | 81% | 62.4K | #597,932 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Antibody Registry
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Antibody Registry
10 companies that operate in the same segment as Antibody Registry (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Antibody Registry
Antibody Registry was founded in 2010.
Antibody Registry is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Antibody Registry, founded in 2010 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, research tools, and antibody databases. Maintains a comprehensive database of antibodies for research professionals. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Antibody Registry's top competitors include Genomenon, Yaorongyun Digital Technology and RareCan.